SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-000551
Filing Date
2020-02-06
Accepted
2020-02-06 08:14:56
Documents
13
Period of Report
2020-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20200113x8k5205c72.htm   iXBRL 8-K 37418
2 EX-99.1 ex-99d1.htm EX-99.1 21500
  Complete submission text file 0001558370-20-000551.txt   184111

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20200113.xsd EX-101.SCH 3290
4 EX-101.LAB bpmc-20200113_lab.xml EX-101.LAB 15497
5 EX-101.PRE bpmc-20200113_pre.xml EX-101.PRE 10526
7 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20200113x8k5205c72_htm.xml XML 4633
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 20580962
SIC: 2834 Pharmaceutical Preparations